Management of Oleander Seed Poisoning
The management of oleander seed poisoning should focus on administering digoxin-specific antibody fragments (digoxin-Fab), which is reasonable for treating yellow oleander poisoning according to the 2023 American Heart Association guidelines. 1
Initial Assessment and Stabilization
Recognize symptoms: Look for gastrointestinal symptoms, confusion, hyperkalemia, and cardiac conduction abnormalities including:
- Bradyarrhythmias
- Atrioventricular nodal block
- Ventricular tachycardia/fibrillation
- Asystole
Continuous ECG monitoring: Monitor for at least 24 hours to detect arrhythmias; longer monitoring for severe cases 2
Laboratory evaluation:
- Serum potassium levels (both hypokalemia and hyperkalemia can occur)
- Serum digoxin levels (can cross-react with oleander cardiac glycosides)
- Renal function tests
Specific Treatment Algorithm
Digoxin-specific antibody fragments (digoxin-Fab):
Cardiac management:
For bradydysrhythmias:
For ventricular dysrhythmias:
- Lidocaine or phenytoin may be reasonable until digoxin-Fab can be administered (Class 2b recommendation) 1
Electrolyte management:
- Correct hyperkalemia with insulin-dextrose infusion
- Avoid calcium administration for hyperkalemia as it increases risk of cardiac arrhythmias 2
- Correct hypokalemia if present as it can worsen cardiac glycoside toxicity
Gastrointestinal decontamination:
Special Considerations
Oxygen therapy: Provide supportive oxygen as needed, but be aware that excessive oxygen may not be beneficial in cellular toxins
Fluid management: Correct dehydration with normal saline and maintain adequate renal perfusion 2
Antiemetics: Control severe vomiting as needed 2
Avoid hemodialysis: Extracorporeal removal methods including hemodialysis, hemofiltration, hemoperfusion, or plasmapheresis are not recommended (Class 3: No Benefit) 1
Prognosis and Monitoring
- Mortality rates vary but can be significantly reduced with proper treatment
- In a study of 300 patients with yellow oleander seed ingestion, 46% developed arrhythmias with sinus bradycardia being the most common (49.27%) 3
- Median hospital stay is approximately 5 days, with most patients (85.33%) having normal ECG at discharge 3
Pitfalls to Avoid
Delaying digoxin-Fab administration: Early administration is critical for severe poisoning
Calcium administration: Avoid intravenous calcium for hyperkalemia as it may precipitate life-threatening arrhythmias 2
Inadequate monitoring: Patients may develop delayed cardiac toxicity; continuous monitoring for at least 24 hours is essential
Underestimating severity: The number of seeds ingested does not reliably predict ECG changes or clinical severity 3
Premature discharge: Ensure cardiac rhythm has stabilized before discharge
The evidence strongly supports the use of digoxin-Fab as the cornerstone of treatment for oleander poisoning, with supportive measures for cardiac arrhythmias and electrolyte abnormalities as needed.